DynaCAD for prostate and DynaTRIM, both part of Invivo’s Prostate Clinical Solution, give physicians the tools to perform real-time analysis of prostate magnetic resonance imaging (MRI) studies and the support for an MRI-guided prostate biopsy. The device was showcased at RSNA 2010.

DynaTRIM is a fully MR-compatible interventional device for transrectal interventional MR biopsy of the prostate gland. It is a removable device that is designed to affix to an imaging table to an open design that allows for flexibility in coil choice and a cleanable foam pad for extra patient comfort. The DynaTRIM needle guide is smaller than the endorectal probe used for traditional transrectal ultrasound (TRUS) biopsies, so it usually is better tolerated by patients.

Invivo also has recently made an agreement with CorTechs Labs to be the key distributor for the NeuroQuant product in the U.S. marketplace. NeuroQuant will augment Invivo’s DynaSuite Neuro Solution by providing enhanced diagnostic capabilities to healthcare practitioners that may help in the assessment of patients with Alzheimer’s, epilepsy and other neurological disorders.

DynaSuite Neuro is an MR neuro solution designed for optimal workflow and repeatable analysis for pediatrics and adults. The data is automatically processed and displayed in predefined layouts, which are customizable for the physician’s preference. The simplified user interface provides the neuroradiologist with the tools to analyze perfusion (PWI), diffusion (DWI) and functional MRI (fMRI) quickly and easily.

DynaSuite Neuro is compatible with all major MRI systems. Data sets from the MR system are automatically sent to DynaSuite Neuro, processed in the background and registered to a high resolution 3-D T1. In each review screen, images are synchronized for easy viewing and correlation.

DynaSuite Neuro is designed to streamline workflow through automated processes. Registration, vessel, skull stripping, diffusion and fMRI QC applications facilitate a visual inspection of results and making adjustments to positioning or thresholds. DynaSuite Neuro also has the ability to create a “results image series” and a final report. The results images as well as the report can be sent to a PACS system and automatically combined with the original study data. The report is converted to a DICOM file and can be viewed with the images. The results images can also be exported to a surgical planning system.


Related Content

News | PET Imaging

April 24, 2024 — A new study from Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare ...

Time April 24, 2024
arrow
News | Radiology Business

April 23, 2024 — A diverse writing group—lead by authors at the University of Toronto—have developed an approach for ...

Time April 23, 2024
arrow
News | FDA

April 23, 2024 — Royal Philips , a global leader in health technology, today announced its Philips Zenition 30 mobile C ...

Time April 23, 2024
arrow
News | Ultrasound Imaging

April 22, 2024 — GE HealthCare announced the launch of the Voluson Signature 20 and 18 ultrasound systems, which ...

Time April 22, 2024
arrow
News | Radiation Therapy

April 18, 2024 — Accuray Incorporated announced that as part of its commitment to advancing patient care the company has ...

Time April 18, 2024
arrow
News | FDA

April 18, 2024 — Lumicell, Inc., a privately held company focused on developing innovative fluorescence-guided imaging ...

Time April 18, 2024
arrow
News | Lung Imaging

April 17, 2024 — A Medicare policy requiring primary care providers (PCPs) to share in the decision-making with patients ...

Time April 17, 2024
arrow
News | Radiology Business

April 17, 2024 — VISTA.AI announced the appointment of Daniel Hawkins as President and CEO. The company is pioneering AI ...

Time April 17, 2024
arrow
News | Magnetic Resonance Imaging (MRI)

April 17, 2024 — Hyperfine, Inc., a groundbreaking health technology company that has redefined brain imaging with the ...

Time April 17, 2024
arrow
News | ACR

April 15, 2023 — The American College of Radiology (ACR) released an update to its ACR Appropriateness Criteria (ACR AC) ...

Time April 13, 2024
arrow
Subscribe Now